cckinase, Inc.

Favorite  |  Set Home
E-mail: info@cckinase.com
Products > JAK/STAT Signaling > JAK > XL-019 (XL019, XL 019)
XL-019 (XL019, XL 019)
Product name : XL-019 (XL019, XL 019)
Product No. : cs-800
Price : 100mg, $475, 500mg/$1275
CAS : 
Bulk inquiry : 
←[Previous Product]              [Next Product]→
Online Inquiry         Email Us

  Details:
XL019 (CAS: 945755-56-6) is a potent and selective JAK2 inhibitor with IC50 of 2.2 nM, 100 fold selectivity over JAK1. XL019 inhibits the activation of JAK2 as well as the mutated form JAK2V617F, which may result in the inhibition of the JAK-STAT signaling pathway and may induce apoptosis. The JAK2 mutated form JAK2V617F has a valine-to-phenylalanine modification at position 617 and plays a key role in tumor cell proliferation and survival.

  Related Products :

JANEX-1 (WHI-P131)
JANEX-1 (WHI-P131)
Price: 100mg/$675; 500mg/$1875

JAK2 Inhibitor V, Z3 (NSC-42834, NSC42834, NSC 42834)
JAK2 Inhibitor V, Z3 (NSC-42834, NSC42834, NSC 42834)
Price: 100mg, $975, 500mg/$2475

Gusacitinib (ASN-002, ASN002, ASN 002)
Gusacitinib (ASN-002, ASN002, ASN 002)
Price: 100mg/$675; 500mg/$1875

GLPG0634 (analog)
GLPG0634 (analog)
Price: 100mg, $675, 500mg/$1875

Filgotinib (GLPG-0634, GLPG 0634; GLPG0634)
Filgotinib (GLPG-0634, GLPG 0634; GLPG0634)
Price: 100mg, $675, 500mg/$1875

Gandotinib (LY-2784544, LY2784544, LY 2784544)
Gandotinib (LY-2784544, LY2784544, LY 2784544)
Price: 100mg/$675; 500mg/$1875

Pacritinib (SB1518; SB 1518; SB-1518)
Pacritinib (SB1518; SB 1518; SB-1518)
Price: 100mg, $475, 500mg/$1275

Deucravacitinib, BMS-986165 (BMS986165, BMS 986165)
Deucravacitinib, BMS-986165 (BMS986165, BMS 986165)
Price: 100mg/$875, 500mg/$2175

Online service

info@cckinase.com